+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Clinical Trial Supply & Logistics for Pharmaceutical Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 185 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4989664
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The clinical trial supply and logistics market is rapidly transforming in response to scientific complexity, regulatory changes, and evolving patient expectations. Senior leaders must now consider integrated supply strategies as a core element of trial feasibility, product safety, and patient experience.

Market Snapshot: Clinical Trial Supply & Logistics for Pharmaceutical Market

The global clinical trial supply and logistics market is experiencing steady growth, expanding from USD 26.35 billion in 2025 to USD 28.38 billion in 2026. With a compound annual growth rate (CAGR) of 8.02%, the market is projected to reach USD 45.24 billion by 2032. The primary keyword, “clinical trial supply and logistics,” anchors the analysis for decision-makers focusing on resilient and compliant supply chains.

Scope & Segmentation Analysis

This report delivers a comprehensive breakdown of the sector by evaluating diverse aspects influencing strategy, operational investments, and vendor relationships:

  • Service Types: Packaging & Labeling, Project Management, Storage & Distribution, Temperature Monitoring, Transportation
  • Trial Phases: Phase I, Phase II, Phase III, Phase IV – each with distinct supply needs
  • Transport Modes: Air Freight (Charter, Standard), Rail Freight (Direct, Intermodal), Road Freight (Ftl, Ltl), Sea Freight (Fcl, Lcl)
  • Temperature Categories: Ambient, Controlled Room, Frozen, Refrigerated – requiring tailored packaging and monitoring solutions
  • Packaging Architectures: Active (Cryogenic Shippers, Refrigeration Units), Hybrid (Combined Solutions, Modular Systems), Passive (Insulated Boxes, Thermal Wraps)
  • End-User Roles: Biotechnology Companies, Clinical Trial Sites, Contract Research Organizations, Pharmaceutical Companies, Third-Party Logistics Providers
  • Key Regions: Americas, Europe Middle East & Africa (EMEA), Asia-Pacific – each shaping supply models based on infrastructure, regulation, and trial distribution

Advanced logistics technology, including IoT-enabled telemetry and digital platforms, is increasingly used to enhance monitoring, ensure temperature control, and inspire new packaging innovations across all segments and regions.

Key Takeaways for Senior Decision-Makers

  • Integrated supply chain capabilities are now critical for aligning clinical operations, regulatory affairs, and logistics, ensuring that protocol requirements translate into executable, resilient plans.
  • Supplier models are evolving: Established providers invest in end-to-end solutions with visibility tools, while specialists offer niche expertise for cryogenic and last-mile clinical deliveries.
  • Strategic sourcing involves performance-driven contracting with measurable outcomes for quality, delivery rates, and regulatory compliance, reducing risks caused by fragmented accountability.
  • Technological advances, such as real-time sensors and cloud-based tracking, enable robust audit trails and proactive management, but also require standardized data exchange and cybersecurity protection.
  • Regional and policy factors—especially in the secondary keyword “trade compliance”—significantly impact routing choices, customs processes, and network resilience, making investment in local partnerships crucial.
  • Environmental sustainability is gaining ground, with reusable and hybrid packaging systems balancing ecological targets and uncompromised thermal safety.

Tariff Impact: Responding to Trade and Customs Complexity

Recent shifts in tariff regimes and increased customs scrutiny are prompting stakeholders to re-evaluate sourcing, routing, and regional assembly strategies. The need for redundancy in transport networks and enhanced documentation procedures is heightened to avoid costly delays for temperature-sensitive products. Adaptive approaches—such as nearshoring, local assembly, and partnership with experienced customs brokers—are being adopted to streamline border controls and maintain supply continuity.

Methodology & Data Sources

The research approach combines primary interviews with clinical supply chain leaders, logistics providers, regulatory experts, and clinical operations managers. Technical validation involved assessments of packaging, storage, and monitoring technologies. Regulatory guidance and up-to-date trade policy were reviewed and triangulated with cross-functional insights to ensure recommendations reflect industry realities. Peer review by subject-matter experts reinforces the report’s validity.

Why This Report Matters

  • Empowers decision-makers with actionable intelligence to align packaging, monitoring, and transport for global compliance and faster study delivery.
  • Supports proactive risk management by examining the impact of trade policies, digital innovation, and sustainability strategies across diverse trial designs and geographies.
  • Enables procurement and clinical leaders to benchmark vendor selection, contract models, and operational investments for improved supply resilience.

Conclusion

Integrated logistics have become a strategic imperative for clinical trial sponsors and providers as scientific and regulatory complexity intensifies. Organizations investing in advanced packaging, telemetry, and regionally tailored distribution can support study integrity and accelerate timelines in a shifting global environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Service Type
8.1. Packaging & Labeling
8.2. Project Management
8.3. Storage & Distribution
8.4. Temperature Monitoring
8.5. Transportation
9. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Phase
9.1. Phase I
9.2. Phase II
9.3. Phase III
9.4. Phase IV
10. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Transportation Mode
10.1. Air Freight
10.1.1. Charter
10.1.2. Standard
10.2. Rail Freight
10.2.1. Direct
10.2.2. Intermodal
10.3. Road Freight
10.4. Sea Freight
11. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Temperature Range
11.1. Ambient
11.2. Controlled Room
11.3. Frozen
11.4. Refrigerated
12. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Packaging Type
12.1. Active Packaging
12.1.1. Cryogenic Shippers
12.1.2. Refrigeration Units
12.2. Hybrid Packaging
12.2.1. Combined Solutions
12.2.2. Modular Systems
12.3. Passive Packaging
12.3.1. Insulated Boxes
12.3.2. Thermal Wraps
13. Clinical Trial Supply & Logistics for Pharmaceutical Market, by End User
13.1. Biotechnology Companies
13.2. Clinical Trial Sites
13.3. Contract Research Organizations
13.4. Pharmaceutical Companies
13.5. Third-Party Logistics Providers
14. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Clinical Trial Supply & Logistics for Pharmaceutical Market
18. China Clinical Trial Supply & Logistics for Pharmaceutical Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Almac Group
19.6. AmerisourceBergen Corporation
19.7. Bilcare Limited
19.8. Biocair International Limited
19.9. Catalent, Inc.
19.10. Clinigen Group PLC
19.11. DHL International GmbH by Deutsche Post AG
19.12. Eurofins Scientific SE
19.13. FedEx Corporation
19.14. ICON PLC
19.15. Infosys Limited
19.16. KLIFO A/S
19.17. Lonza Group
19.18. Metrics Contract Services by Mayne Pharma group
19.19. Movianto
19.20. Parexel International Corporation
19.21. PCI Pharma Services
19.22. Seveillar Clinical Trial Supplies Pvt. Ltd.
19.23. SIRO Clinpharm Private Limited
19.24. Thermo Fisher Scientific, Inc.
19.25. UDG Healthcare PLC
List of Figures
FIGURE 1. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING & LABELING, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING & LABELING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING & LABELING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PROJECT MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PROJECT MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PROJECT MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STORAGE & DISTRIBUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STORAGE & DISTRIBUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STORAGE & DISTRIBUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE I, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE I, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE I, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE II, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE II, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE II, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE III, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE III, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE III, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE IV, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE IV, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE IV, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CHARTER, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CHARTER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CHARTER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STANDARD, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STANDARD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY DIRECT, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY DIRECT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INTERMODAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INTERMODAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INTERMODAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AMBIENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AMBIENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AMBIENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CONTROLLED ROOM, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CONTROLLED ROOM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CONTROLLED ROOM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY FROZEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY FROZEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY FROZEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REFRIGERATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REFRIGERATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REFRIGERATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CRYOGENIC SHIPPERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CRYOGENIC SHIPPERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CRYOGENIC SHIPPERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REFRIGERATION UNITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REFRIGERATION UNITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REFRIGERATION UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COMBINED SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COMBINED SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COMBINED SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MODULAR SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MODULAR SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MODULAR SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INSULATED BOXES, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INSULATED BOXES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INSULATED BOXES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERMAL WRAPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERMAL WRAPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERMAL WRAPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL SITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL SITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL SITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THIRD-PARTY LOGISTICS PROVIDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THIRD-PARTY LOGISTICS PROVIDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THIRD-PARTY LOGISTICS PROVIDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 169. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 170. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
TABLE 171. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
TABLE 172. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
TABLE 173. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
TABLE 174. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 175. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 176. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
TABLE 177. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 178. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 190. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 193. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 194. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
TABLE 195. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
TABLE 196. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
TABLE 197. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
TABLE 198. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 199. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 200. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
TABLE 201. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 202. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 216. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 218. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 219. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
TABLE 220. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
TABLE 221. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
TABLE 222. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
TABLE 223. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 224. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 225. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
TABLE 226. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 227. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 228. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 229. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 230. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 231. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
TABLE 232. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
TABLE 233. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
TABLE 234. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
TABLE 235. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 236. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 237. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
TABLE 238. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 239. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-

Companies Mentioned

The key companies profiled in this Clinical Trial Supply & Logistics for Pharmaceutical market report include:
  • Almac Group
  • AmerisourceBergen Corporation
  • Bilcare Limited
  • Biocair International Limited
  • Catalent, Inc.
  • Clinigen Group PLC
  • DHL International GmbH by Deutsche Post AG
  • Eurofins Scientific SE
  • FedEx Corporation
  • ICON PLC
  • Infosys Limited
  • KLIFO A/S
  • Lonza Group
  • Metrics Contract Services by Mayne Pharma group
  • Movianto
  • Parexel International Corporation
  • PCI Pharma Services
  • Seveillar Clinical Trial Supplies Pvt. Ltd.
  • SIRO Clinpharm Private Limited
  • Thermo Fisher Scientific, Inc.
  • UDG Healthcare PLC

Table Information